{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T04:11:48Z","timestamp":1790223108052,"version":"4.1.0"},"reference-count":44,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2022,10,7]],"date-time":"2022-10-07T00:00:00Z","timestamp":1665100800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"United States (U.S.) Department of Veterans Affairs Rehabilitation Research and Development Service","award":["1I50RX003002-01"],"award-info":[{"award-number":["1I50RX003002-01"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomolecules"],"abstract":"<jats:p>Acute optic neuritis (ON) is a common cause of vision loss and is often associated with multiple sclerosis (MS). Cholesterol recycling has been identified as a key limiting factor in recovery after demyelination events. Thus, the purpose of our study was to determine if the augmentation of cholesterol transport by gentisic acid (GA) benefits retinal ganglion cell (RGC) development and myelination in organoid systems and enables the recovery of the ocular phenotype upon systemic GA treatment in a MOG-induced experimental autoimmune encephalomyelitis (EAE) ON model. The retinal organoids treated with GA demonstrate an accelerated maturation when compared to the conventionally derived organoids, which was evidenced by the improved organization of Brn3a-GFP+RGC and increased synaptogenesis. A GA supplementation in brain organoids leads to a 10-fold increase in NG2 and Olig2 expression. Weekly GA injections of EAE mice significantly lessened motor-sensory impairment, protected amplitudes in pattern electroretinogram recordings, and preserved visual acuity over the study period of 56 days. Furthermore, GA-treated EAE mice revealed diminished GCL\/IPL complex thinning when compared to the untreated EAE mice. An optic nerve histopathology revealed less severe grades of demyelination in the GA-treated EAE cohort and fewer infiltrating cells were observed. Interventions to improve cholesterol homeostasis may be a viable approach to promoting the rehabilitation of MS patients.<\/jats:p>","DOI":"10.3390\/biom12101437","type":"journal-article","created":{"date-parts":[[2022,10,8]],"date-time":"2022-10-08T00:07:43Z","timestamp":1665187663000},"page":"1437","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Targeting Cholesterol Homeostasis Improves Recovery in Experimental Optic Neuritis"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5573-3311","authenticated-orcid":false,"given":"Cheyanne R.","family":"Godwin","sequence":"first","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, University of Iowa, Iowa City, IA 52242, USA"},{"name":"Center for the Prevention and Treatment of Visual Loss, Iowa City VA Health Care System, Iowa City, IA 52246, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey J.","family":"Anders","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, University of Iowa, Iowa City, IA 52242, USA"},{"name":"Center for the Prevention and Treatment of Visual Loss, Iowa City VA Health Care System, Iowa City, IA 52246, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4960-8186","authenticated-orcid":false,"given":"Lin","family":"Cheng","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, University of Iowa, Iowa City, IA 52242, USA"},{"name":"Center for the Prevention and Treatment of Visual Loss, Iowa City VA Health Care System, Iowa City, IA 52246, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5289-0645","authenticated-orcid":false,"given":"Benjamin W.","family":"Elwood","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, University of Iowa, Iowa City, IA 52242, USA"},{"name":"Center for the Prevention and Treatment of Visual Loss, Iowa City VA Health Care System, Iowa City, IA 52246, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3173-7123","authenticated-orcid":false,"given":"Randy H.","family":"Kardon","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, University of Iowa, Iowa City, IA 52242, USA"},{"name":"Center for the Prevention and Treatment of Visual Loss, Iowa City VA Health Care System, Iowa City, IA 52246, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver W.","family":"Gramlich","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, University of Iowa, Iowa City, IA 52242, USA"},{"name":"Center for the Prevention and Treatment of Visual Loss, Iowa City VA Health Care System, Iowa City, IA 52246, USA"},{"name":"Department of Neuroscience and Pharmacology, University of Iowa, Iowa City, IA 52242, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,10,7]]},"reference":[{"key":"ref_1","first-page":"1236","article-title":"Optic Neuritis","volume":"25","author":"Bennett","year":"2019","journal-title":"Contin. (Minneapolis, Minn.)"},{"key":"ref_2","first-page":"82","article-title":"Optic neuritis: A review","volume":"16","author":"Shams","year":"2009","journal-title":"Int. MS J."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1056\/NEJM199202273260901","article-title":"A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group","volume":"326","author":"Beck","year":"1992","journal-title":"N. Engl. J. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0002-9394(03)00862-6","article-title":"Visual function more than 10 years after optic neuritis: Experience of the optic neuritis treatment trial","volume":"137","author":"Beck","year":"2004","journal-title":"Am. J. Ophthalmol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00415-020-10352-1","article-title":"The changing landscape of optic neuritis: A narrative review","volume":"269","author":"Bennett","year":"2022","journal-title":"J. Neurol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/WNO.0000000000000421","article-title":"20\/40 or Better Visual Acuity After Optic Neuritis: Not as Good as We Once Thought?","volume":"36","author":"Sabadia","year":"2016","journal-title":"J. Neuroophthalmol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S1474-4422(17)30278-8","article-title":"Retinal layer segmentation in multiple sclerosis: A systematic review and meta-analysis","volume":"16","author":"Petzold","year":"2017","journal-title":"Lancet Neurol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"10371","DOI":"10.1038\/s41598-019-46251-3","article-title":"In vivo structural and functional assessment of optic nerve damage in neuromyelitis optica spectrum disorders and multiple sclerosis","volume":"9","author":"Vabanesi","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"4587","DOI":"10.1007\/s00415-020-10275-x","article-title":"Contributions of T cells in multiple sclerosis: What do we currently know?","volume":"268","author":"Arneth","year":"2021","journal-title":"J. Neurol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/S1474-4422(21)00063-6","article-title":"Cellular immunology of relapsing multiple sclerosis: Interactions, checks, and balances","volume":"20","author":"Li","year":"2021","journal-title":"Lancet Neurol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1136\/bmj.332.7540.525","article-title":"Diagnosis and treatment of multiple sclerosis","volume":"332","author":"Murray","year":"2006","journal-title":"BMJ"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/S1474-4422(19)30391-6","article-title":"Advances in oral immunomodulating therapies in relapsing multiple sclerosis","volume":"19","author":"Derfuss","year":"2020","journal-title":"Lancet Neurol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.msard.2016.06.001","article-title":"Comparative efficacy of disease-modifying therapies for patients with relapsing remitting multiple sclerosis: Systematic review and network meta-analysis","volume":"9","author":"Fogarty","year":"2016","journal-title":"Mult. Scler. Relat. Disord."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1111\/j.1468-1331.2008.02258.x","article-title":"Treatment of corticosteroid refractory optic neuritis in multiple sclerosis patients with intravenous immunoglobulin","volume":"15","author":"Tselis","year":"2008","journal-title":"Eur. J. Neurol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1212\/01.WNL.0000138437.99046.6B","article-title":"Plasma exchange for severe optic neuritis: Treatment of 10 patients","volume":"63","author":"Ruprecht","year":"2004","journal-title":"Neurology"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Gugliandolo, A., Bramanti, P., and Mazzon, E. (2020). Mesenchymal Stem Cells in Multiple Sclerosis: Recent Evidence from Pre-Clinical to Clinical Studies. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21228662"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Florou, D., Katsara, M., Feehan, J., Dardiotis, E., and Apostolopoulos, V. (2020). Anti-CD20 Agents for Multiple Sclerosis: Spotlight on Ocrelizumab and Ofatumumab. Brain Sci., 10.","DOI":"10.3390\/brainsci10100758"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1038\/s41598-017-02638-8","article-title":"Expression profiles of cholesterol metabolism-related genes are altered during development of experimental autoimmune encephalomyelitis in the rat spinal cord","volume":"7","author":"Lavrnja","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/s41593-020-00757-6","article-title":"Microglia facilitate repair of demyelinated lesions via post-squalene sterol synthesis","volume":"24","author":"Berghoff","year":"2021","journal-title":"Nat. Neurosci."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1167\/tvst.9.8.16","article-title":"Systemic Mesenchymal Stem Cell Treatment Mitigates Structural and Functional Retinal Ganglion Cell Degeneration in a Mouse Model of Multiple Sclerosis","volume":"9","author":"Gramlich","year":"2020","journal-title":"Transl. Vis. Sci. Technol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1126\/science.aan4183","article-title":"Defective cholesterol clearance limits remyelination in the aged central nervous system","volume":"359","author":"Fitzner","year":"2018","journal-title":"Science"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12944-019-0965-z","article-title":"Role of cholesterol and sphingolipids in brain development and neurological diseases","volume":"18","author":"Hussain","year":"2019","journal-title":"Lipids Health Dis."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.preteyeres.2014.03.002","article-title":"Cholesterol in the retina: The best is yet to come","volume":"41","author":"Pikuleva","year":"2014","journal-title":"Prog. Retin. Eye Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.cmet.2013.03.009","article-title":"Impaired cholesterol efflux in senescent macrophages promotes age-related macular degeneration","volume":"17","author":"Sene","year":"2013","journal-title":"Cell Metab."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e120824","DOI":"10.1172\/jci.insight.120824","article-title":"Impaired monocyte cholesterol clearance initiates age-related retinal degeneration and vision loss","volume":"3","author":"Ban","year":"2018","journal-title":"JCI Insight"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e45100","DOI":"10.7554\/eLife.45100","article-title":"Impaired ABCA1\/ABCG1-mediated lipid efflux in the mouse retinal pigment epithelium (RPE) leads to retinal degeneration","volume":"8","author":"Storti","year":"2019","journal-title":"Elife"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.bbadis.2014.01.010","article-title":"Regulation of the cholesterol efflux transporters ABCA1 and ABCG1 in retina in hemochromatosis and by the endogenous siderophore 2,5-dihydroxybenzoic acid","volume":"1842","author":"Ananth","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/ptr.6573","article-title":"A review on gentisic acid as a plant derived phenolic acid and metabolite of aspirin: Comprehensive pharmacology, toxicology, and some pharmaceutical aspects","volume":"34","author":"Abedi","year":"2020","journal-title":"Phytother. Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"14092","DOI":"10.1016\/S0021-9258(17)38687-8","article-title":"Inhibition of cyclooxygenase mediated by electrochemical oxidation of gentisic acid","volume":"260","author":"Holmes","year":"1985","journal-title":"J. Biol. Chem."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.stem.2012.05.009","article-title":"Self-formation of optic cups and storable stratified neural retina from human ESCs","volume":"10","author":"Nakano","year":"2012","journal-title":"Cell Stem Cell"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1093\/stmcls\/sxac017","article-title":"Absence of Connexin 43 results in smaller retinas and arrested, depolarized retinal progenitor cells in human retinal organoids","volume":"40","author":"Cheng","year":"2022","journal-title":"Stem Cells"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/s41592-018-0081-4","article-title":"Induction of myelinating oligodendrocytes in human cortical spheroids","volume":"15","author":"Madhavan","year":"2018","journal-title":"Nat. Methods"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nprot.2008.73","article-title":"Analyzing real-time PCR data by the comparative C(T) method","volume":"3","author":"Schmittgen","year":"2008","journal-title":"Nat. Protoc."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.2042-7158.2011.01393.x","article-title":"Modulatory effects of gentisic acid against genotoxicity and hepatotoxicity induced by cyclophosphamide in Swiss albino mice","volume":"64","author":"Nafees","year":"2012","journal-title":"J. Pharm. Pharm."},{"key":"ref_35","first-page":"e51275","article-title":"Myelin oligodendrocyte glycoprotein (MOG35-55) induced experimental autoimmune encephalomyelitis (EAE) in C57BL\/6 mice","volume":"86","author":"Bittner","year":"2014","journal-title":"J. Vis. Exp. JoVE"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"4611","DOI":"10.1167\/iovs.04-0541","article-title":"Rapid quantification of adult and developing mouse spatial vision using a virtual optomotor system","volume":"45","author":"Prusky","year":"2004","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Zeng, H., Dumitrescu, A.V., Wadkins, D., Elwood, B.W., Gramlich, O.W., and Kuehn, M.H. (2022). Systemic Treatment with Pioglitazone Reverses Vision Loss in Preclinical Glaucoma Models. Biomolecules, 12.","DOI":"10.3390\/biom12020281"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1167\/iovs.14-13943","article-title":"Robust mouse pattern electroretinograms derived simultaneously from each eye using a common snout electrode","volume":"55","author":"Chou","year":"2014","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1007\/s00401-021-02370-8","article-title":"Analyzing microglial phenotypes across neuropathologies: A practical guide","volume":"142","author":"Schwabenland","year":"2021","journal-title":"Acta Neuropathol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/WNO.0b013e3182745600","article-title":"Retinal ganglion cell functional plasticity and optic neuropathy: A comprehensive model","volume":"32","author":"Porciatti","year":"2012","journal-title":"J. Neuroophthalmol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"8518","DOI":"10.1038\/ncomms9518","article-title":"Neuronal activity regulates remyelination via glutamate signalling to oligodendrocyte progenitors","volume":"6","author":"Gautier","year":"2015","journal-title":"Nat. Commun."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1136\/pgmj.28.317.179","article-title":"Some new drugs in the treatment of rheumatic fever","volume":"28","author":"Smith","year":"1952","journal-title":"Postgrad. Med. J."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.4014\/jmb.2105.05004","article-title":"Modulation of Inflammatory Pathways and Adipogenesis by the Action of Gentisic Acid in RAW 264.7 and 3T3-L1 Cell Lines","volume":"31","author":"Kang","year":"2021","journal-title":"J. Microbiol. Biotechnol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1007\/s13311-017-0577-0","article-title":"Remyelinating Pharmacotherapies in Multiple Sclerosis","volume":"14","author":"Bove","year":"2017","journal-title":"Neurotherapeutics"}],"container-title":["Biomolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-273X\/12\/10\/1437\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:47:56Z","timestamp":1760143676000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-273X\/12\/10\/1437"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,7]]},"references-count":44,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2022,10]]}},"alternative-id":["biom12101437"],"URL":"https:\/\/doi.org\/10.3390\/biom12101437","relation":{},"ISSN":["2218-273X"],"issn-type":[{"value":"2218-273X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,7]]}}}